Skip to main content
. 2020 Nov 5;22:262. doi: 10.1186/s13075-020-02345-2

Table 1.

Clinical characteristics of the juvenile idiopathic arthritis (JIA) cohort and control group

Characteristics Juvenile idiopathic arthritis Control
Total no. assessed Values Total no. assessed Values
Female sex 96 68 (71) 109 77 (71)
Fulltime school or work 94 73 (78) 109 86 (79)
Age at visit, years, median (IQR) 96 22.7 (18.7–26.2) 109 23.5 (20.2–26.7)
Age at disease onset, years, median (IQR) 96 6.4 (2.7–11.7)
Disease duration at visit, years, median (IQR) 96 16.1 (14.2–17.1)
Oligoarticular JIA at onset 96 51 (53)
Oligoarticular JIA at visita 96 45 (47)
Not in remission at visitb 96 53 (55)
DMARDs and/or biologics at visit 96 34 (35)
HAQ, median (IQR) 96 0 (0.0–0.125)
Women: hormonal contraceptives 68 42 (62) 74 48 (65)
Women: days since LMP, median (IQR) 54 14 (6–26) 69 19 (9–39)
Alcohol consumption at day of visitc 95 0 (0) 109 2 (2)
Use of tobacco at day of visitc 93 21 (23) 106 22 (21)
Consumption of coffee/tea/cola at day of visitc 95 36 (38) 109 28 (26)
Pain or psychotropic medication at day of visitd 95 4 (4) 107 2 (2)
SF-36 PCS, mean (± SD) 96 51.1 (± 9.5) 109 55.1 (± 7.9)
SF-36 MCS, mean (± SD) 96 47.7 (± 11.6) 109 47.5 (± 9.7)

Unless otherwise stated, values indicate numbers (%); no. numbers; IQR interquartile range, 1st–3rd; DMARDs disease-modifying anti-rheumatic drugs; biologics biologic drugs; HAQ Health Assessment Questionnaire, 0–3 (0 = lowest, 3 = highest); LMP last menstrual period; SD standard deviation; SF-36 Short-form 36 Health Status Questionnaire, 0–100 (< 40 poor health); PCS physical component summary; MCS mental component summary

aPersistent (no. = 27) and extended (no. = 18) oligoarticular disease

bNot in remission off medication for ≥ 12 months according to the definition by Wallace et al.

cConsumption after 00.00 on the day of visit

dPain or psychotropic medication after 00.00 on the day of visit, including JIA: ibuprofen (n = 1), methylphenidate (n = 2), and prednisolone (n = 1) and control: paracetamol (n = 1) and lisdexamfetamine (n = 1)